EU regulator is reviewing weight-loss drugs Ozempic and Wegovy for risk of suicidal thoughts and self-harm
July 11, 2023 at 14:20 PM EDT
The European Medicines Agency is reviewing data on the popular new class of drugs used for weight loss and Type 2 diabetes.
